| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.15 | 0.0007 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |